Avantor (AVTR) Stock Price, Quote, News & History | Benzinga

SPY774.94+0.01%QQQ756.43+0.03%BTC/USD85,549.29−0.23%DIA512.59+0.09%GLD379.00−0.14%TLT77.13+0.03%

Avantor Inc (AVTR) Stock Price, Quote, News & History

AVTRNYSE

Trade with Public

Trade with Public

$15.81

0.473.06%

Last update: Oct 5, 5:06 PM

$15.05

-0.29-1.89%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$15.34

Close

$15.81

Volume / Avg.

8.18M / 9.35M

Day Range

$15.24 - $15.87

52 Wk Range

7.27 - 16.05

Market Cap

$10.18B

P/E Ratio

-

Dividend Yield

-

Exchange

NYSE

RSI

53

Short Interest

9.22%

Days to Cover

6.19

Recent Avantor, Inc. News

Oil Spikes 7%, Nasdaq 100 Sinks Before Fed: Stock Market Today

Crude surges 7% as Trump vows strikes on Iran and stocks slide ahead of the Fed's decision, with earnings crushing Parsons, Lennox, Watsco and Vertiv.

Piero Cingari

Tango Therapeutics, American Battery Technology, Intel And Other Big Stocks Moving Higher On Monday

U.S. stocks higher, Nasdaq Composite up 1%. Tango Therapeutics (TNGX) shares up 34.1% on positive trial data. Other big gainers include ENHA, JLHL, ABAT, BTGO, GLXY, CLYM, SOC, SRAD, AIAI, ALOY, and GENI.

Avi Kapoor

Braze Posts Mixed Q1 Results, Joins Sidus Space, Everpure And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

US stock futures lower, Braze Inc (BRZE) shares drop 8.4% in pre-market trading after reporting mixed Q1 results. Other stocks also down.

Avi Kapoor

Alpha Buying: Following Conviction, Not the Crowd

Tim Melvin

EXCLUSIVE: Petrochemical Crunch From Iran War Isn't Hitting Hospitals Yet—But Analysts Say Costs For Critical Medical Supplies Could Rise Within Weeks

Oil prices have risen. Here's how Strait of Hormuz tensions could soon increase healthcare costs and make everyday medical supplies more expensive.

Eva Mathew

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

597.00M

Investing Cash Flow (TTM)

-143.00M

Financing Cash Flow (TTM)

-588.50M

Free Cash Flow (TTM)

454.70M

Capital Expenditure (TTM)

-142.30M

Net Change in Cash (TTM)

-134.50M

Analyst Trends and Forecast

1

1

Apr

0

0

0

0

May

1

2

Jun

1

2

Jul

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.6

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$13.77B

PE Ratio (TTM)

-

PE Ratio (FWD)

17.54

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.59

PB Ratio (TTM)

1.84

Earnings Yield % (TTM)

-5.54%

Earnings Yield % (FWD)

5.70%

EV / EBITDA (TTM)

121.93

Price / EBITDA (TTM)

92.18

Price / Free Cash Flow (TTM)

22.89

Book Value / Share

$8.32

Company Debt

Total Debt

$3.70B

LT Debt

$3.66B

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$1.61B

Total Cash

$306.80M

Debt to Equity

0.66

Issuance of Debt (TTM)

-$498.10M

Repayment of Debt (TTM)

-$1.61B